Edgewise Therapeutics
EWTX
EWTX
95 hedge funds and large institutions have $539M invested in Edgewise Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
1.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
40
Reduced
23
Closed
3
Calls
$124K
Puts
$47K
Net Calls
+$77K
Net Calls Change
+$130K
Top Buyers
1 |
Viking Global Investors
Stamford,
Connecticut
|
+$8.01M |
2 |
Goldman Sachs
New York
|
+$7.75M |
3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$5.52M |
4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.04M |
5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.7M |